These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Origins of the prohibition against off-label promotion. Coleman TS. Food Drug Law J; 2014; 69(2):161-236, i. PubMed ID: 25163210 [Abstract] [Full Text] [Related]
4. Off-label use of medical devices in radiology: regulatory standards and recent developments. Smith JJ. J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085 [Abstract] [Full Text] [Related]
9. Criminalizing knowledge: the perverse implications of the intended use regulations of off-label promotion prosecutions. Gentry G. Food Drug Law J; 2009; 64(3):441-58. PubMed ID: 19999637 [Abstract] [Full Text] [Related]
10. Medical device labeling and advertising: an overview. Basile EM, Armentrout E, Reeves KN. Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451 [Abstract] [Full Text] [Related]
14. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use. Meadows WA, Hollowell BD. Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389 [Abstract] [Full Text] [Related]
15. False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Kesselheim AS, Darby D, Studdert DM, Glynn R, Levin R, Avorn J. Health Aff (Millwood); 2011 Dec; 30(12):2318-27. PubMed ID: 22147859 [Abstract] [Full Text] [Related]
19. Advertising and promotion of medical devices. Portnoy S. J Health Law; 2006 Dec; 39(2):265-82. PubMed ID: 17002234 [Abstract] [Full Text] [Related]
20. Marketing nutrition & health-related benefits of food & beverage products: enforcement, litigation & liability issues. Roller S, Pippins R. Food Drug Law J; 2010 Dec; 65(3):447-69, i. PubMed ID: 24479235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]